NCT00234676View on ClinicalTrials.gov

POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Parkinson's Disease
Interventions
DRUG

Premarin ®

Premarin ® 0.625 mg per day orally

Trial Locations (6)

Unknown

The Parkinson's Institute, Sunnyvale

Emory University, Atlanta

Indiana University School of Medicine, Indianapolis

University of Maryland, Baltimore

University of Rochester, Rochester

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

collaborator

Joseph and Rosalyn Newman Foundation

UNKNOWN

lead

The Parkinson Study Group

NETWORK

NCT00234676 - POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease | Biotech Hunter | Biotech Hunter